Recent findings suggest that FAK plays a key role in development offibrotic disorders, and it appears to be an attractive target forantifibrotic therapy and has potential as a future therapeutic target to
counteract fibrosis. PubMed, BioDrugs. 2012 Nov 27. (Also see: Pulmonary Fibrosis Research)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.